Evidence map›Paper›PMID 32500224›Full record

ArticleAnnals of hematology2021

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report.

Zhiliang Hu, Wei Chen, Wenyan Liang, Chuanjun Xu, Wenkui Sun, Yongxiang Yi

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Hematological Abnormalities in COVID-19: A Narrative Review.The American journal of tropical medicine and hygiene · 2021
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiliang HuNanjing Infectious Disease Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Wei ChenDepartment of Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Wenyan LiangDepartment of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Chuanjun XuDepartment of Radiology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Wenkui SunDepartment of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China. sunwenkui@njmu.edu.cn.ORCID 0000-0002-2992-9783
Yongxiang YiNanjing Infectious Disease Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China. ian0126@126.com.

Funding

Nanjing medical science and technique development foundation ZKX17040National Natural Science Foundation of China NSFC 81770009project of Jiangsu province medical youth talent QNRC2016059
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntiviral AgentsCOVID-19COVID-19 Drug TreatmentFemaleGlucocorticoidsHumansImmunosuppressive AgentsMethylprednisolonePurpura, Thrombocytopenic, IdiopathicSARS-CoV-2Antiviral AgentsGlucocorticoidsImmunosuppressive AgentsMethylprednisolone

Identifiers

PMID32500224
PMCPMC7270513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.